Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Journal: Science

Published: 2020-08-21

DOI: 10.1126/science.abd0827

Affiliations: 5

Authors: 47

Go to article
Institutions Share
Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.89
Department of Microbiology and Immunology, UMB, United States of America (USA) 0.09
National Centre for Infectious Diseases (NCID), Singapore 0.01
Tan Tock Seng Hospital (TTSH), Singapore 0.01
Lee Kong Chian School of Medicine, Singapore 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER